In vivo, OCS significantly reduced tumor growth and disrupted Hsp90–Cdc37 co-localization in xenografts with minimal toxicity.37 These findings establish OCS as a promising lead compound for selectively modulating chaperone–cochaperone interactions in cancer therapy. The gene discussed is CDC37; the disease is cancer.